Latest Strategic Investment News

AuMEGA Metals has launched a C$10 million private placement to fund an extensive drilling program targeting high-potential gold and base metal prospects in Newfoundland’s Cape Ray District. The financing aims to unlock value from its significant mineral resources and strategic landholdings.

Alkane Resources Ltd has reported a remarkable half-year surge in revenue and profit, driven by its strategic merger with Mandalay Resources Corporation and soaring gold prices.

dusk Group Limited reported a 5.1% rise in half-year sales to $91.8 million, driven by strong online growth and product innovation, while declaring a fully franked interim dividend of 4.0 cents per share.

Nick Scali Limited reported a robust 29% rise in net profit after tax for the first half of FY26, driven by strong growth in its ANZ operations despite ongoing UK store refurbishments and rebranding efforts.

Civmec Limited reports a 24.3% drop in revenue and a 19% fall in net profit for the half year ended December 2025, while advancing its naval shipbuilding footprint through the acquisition of Luerssen Australia.

Bannerman Energy has secured a landmark $321.5 million strategic investment from CNNC Overseas Limited to jointly develop the Etango Uranium Project in Namibia, enabling debt-free construction and a market-priced offtake agreement with a Tier-1 nuclear utility.

BPH Global has clarified the timing and rationale behind its disclosure of a binding Memorandum of Understanding with Indonesia’s National Research and Innovation Agency, confirming compliance with ASX rules.

US1 Critical Minerals has provided clarity on the issuance of 50 million fee options to consultants related to its December 2025 placement, reaffirming shareholder approval is pending and no funds will be raised from this issuance.

WT Financial Group has delivered a robust half-year performance with underlying net revenue up 19.3% and net profit after tax rising 14.4%, driven by adviser productivity and strategic investments.

ASX Limited reported robust half-year results with an 11.2% rise in operating revenue and a steady net profit, while advancing its technology upgrade and responding to regulatory scrutiny.

Pro Medicus Limited reported a robust half-year performance, with underlying profit after tax rising by approximately 30%, driven by significant new sales and strategic implementations. The company remains confident in its proprietary technology's resilience against AI disruption while expanding its market footprint.

Pro Medicus Limited has reported a stellar half-year performance with revenue up 28.4% and a surge in net profit, driven by major US contract wins and strategic investments.